Dog Cancer Stages: Understanding How Vets Stage Lymphoma and Other Cancers

If your dog has been diagnosed with cancer, one of the first things your veterinarian will determine is the stage. Staging tells you how far the cancer has spread through your dog's body, and it plays a major role in deciding which treatment approach will give your dog the best outcome.

While the staging systems vary depending on the type of cancer, understanding the basics can help you have more informed conversations with your vet and feel more confident about the treatment plan ahead.

‍

What Does Cancer Staging Mean?

Cancer staging is a way of describing the extent of disease in the body at the time of diagnosis. In the simplest terms, it answers the question: How much cancer is there, and where is it?

Staging matters because it directly influences several critical decisions: the treatment approach your veterinarian recommends, the expected prognosis and survival time, how aggressively the cancer needs to be treated, and whether surgery, chemotherapy, radiation, or a combination is most appropriate. Without accurate staging, your veterinarian would be making treatment decisions without a complete picture of what they're dealing with.

A cancer caught at an early stage with limited spread generally has a better prognosis than one that has already reached multiple organs. But staging isn't destiny — many dogs with advanced-stage cancer still respond well to treatment and enjoy a good quality of life. Staging gives your oncologist a starting point, not a final verdict.

‍

The General TNM Staging System

For most solid tumors in dogs — such as mast cell tumors, osteosarcoma, and mammary tumors — veterinarians use the TNM system, which stands for Tumor, Node, and Metastasis. This system was originally developed for human cancers and has been adapted for use in veterinary medicine by the World Health Organization.¹

Tumor (T) describes the size and extent of the primary tumor. T1 is typically a small, localized tumor, while T3 or T4 indicates a large tumor or one that has invaded surrounding tissue. For some cancer types, the T classification also considers whether the tumor is superficial or deeply invasive, which affects surgical options.

Node (N) indicates whether the cancer has spread to nearby (regional) lymph nodes. N0 means no lymph node involvement, while N1 or higher means cancer cells have been found in regional lymph nodes. Lymph node involvement is particularly important because it often signals that cancer cells have gained the ability to travel through the lymphatic system — which may mean distant spread is occurring or imminent.

Metastasis (M) tells you whether the cancer has spread to distant parts of the body. M0 means no distant spread has been detected, while M1 means the cancer has metastasized to other organs like the lungs, liver, or bones. The presence of distant metastasis typically indicates a more advanced disease that requires systemic treatment rather than localized approaches like surgery alone.

These three factors are combined to assign an overall stage, typically ranging from Stage I (early, localized disease) to Stage IV (advanced, widespread disease). Each cancer type has its own specific criteria for what qualifies as each stage, so a Stage III mast cell tumor doesn't necessarily mean the same thing as a Stage III mammary tumor.

‍

How Lymphoma Staging Works Differently

Lymphoma uses its own staging system because it behaves fundamentally differently from solid tumors. Since lymphoma originates in the lymphatic system — which runs throughout the entire body — it's already a systemic disease by nature. You can't simply measure a single tumor's size because the cancer affects an entire organ system that spans from head to tail.

The World Health Organization (WHO) staging system for canine lymphoma uses Stages I through V, with increasing levels of disease involvement:^1,3

Stage I: Cancer is found in only a single lymph node or lymphoid tissue in a single organ. This is relatively rare at diagnosis because lymphoma typically spreads through the lymphatic system before clinical signs are noticed.

Stage II: Multiple lymph nodes are affected, but only on one side of the diaphragm (either all in the chest area or all in the abdomen). This means the disease is still somewhat regionalized.

Stage III: Lymph nodes on both sides of the diaphragm are involved — meaning the disease has spread throughout the lymphatic system. This is actually the most commonly diagnosed stage, because multicentric lymphoma often presents with generalized lymph node enlargement by the time pet parents notice something is wrong.^2,3

Stage IV: The liver and/or spleen are involved in addition to lymph node disease. These organs contain significant lymphoid tissue and are common sites for lymphoma spread. Your veterinarian may detect liver or spleen involvement through abdominal ultrasound, blood work showing elevated liver enzymes, or finding an enlarged spleen during a physical exam.

Stage V: The cancer has spread to the bone marrow, blood, or other organs outside the lymphatic system (such as the eyes, skin, or central nervous system). This represents the most advanced disease, where lymphoma cells have essentially entered the bloodstream or invaded organs that aren't part of the normal lymphatic network.

Substage Classification: A vs. B

Each stage also receives a substage classification that is extremely important for prognosis:

Substage A means the dog appears clinically healthy, with no outward symptoms of illness. They're eating normally, maintaining their weight, and acting like their usual self — despite having cancer. Many dogs are substage A at diagnosis because their pet parents simply noticed swollen lymph nodes during routine petting.

Substage B means the dog is showing clinical signs of illness such as vomiting, diarrhea, significant weight loss, fever, or profound lethargy. These signs indicate that the cancer is taking a toll on the body's ability to function normally.

The substage classification is one of the most important prognostic factors. Dogs with substage A consistently have better outcomes than dogs with substage B, regardless of the stage number.⁶ A dog with Stage IV substage A disease may actually have a better prognosis than a dog with Stage III substage B disease. This is because substage B indicates the body is struggling to cope, which correlates with a less favorable response to treatment.^3,6

You can dive deeper into the different types of canine lymphoma and how type and stage interact to affect your dog's treatment options.

‍

How Your Veterinarian Determines the Stage

Staging isn't just a visual assessment — it requires specific diagnostic tests to get an accurate picture of how far the cancer has spread. For lymphoma, a full staging workup typically includes:

• A thorough physical examination to assess lymph node size and symmetry in multiple locations throughout the body
• A complete blood count (CBC) to check for anemia, abnormal white blood cell counts, or circulating lymphoma cells
• A serum chemistry panel to evaluate liver and kidney function and check for hypercalcemia (elevated calcium), which is seen in some lymphoma cases and carries prognostic significance^1,4
• A urinalysis to assess kidney function
• A fine needle aspirate or biopsy of affected lymph nodes to confirm the diagnosis and determine the cell type
• Chest X-rays (thoracic radiographs) to check for enlarged mediastinal lymph nodes or lung involvement
• An abdominal ultrasound to evaluate the liver, spleen, abdominal lymph nodes, and other organs for signs of infiltration
• A bone marrow aspirate to determine whether lymphoma cells have infiltrated the bone marrow (Stage V disease)

Your oncologist may also recommend flow cytometry or immunohistochemistry, specialized tests that identify whether the lymphoma is B-cell or T-cell type. This distinction matters significantly because B-cell lymphomas generally respond better to treatment than T-cell variants, with longer remission durations and survival times.^1,2

While the staging workup involves multiple tests and some expense, the information it provides is invaluable. Accurate staging ensures your dog receives the most appropriate treatment and gives you the most realistic picture of what to expect going forward.

‍

How Stage Affects Treatment and Prognosis

In general, dogs diagnosed at earlier stages with substage A have better outcomes. Here's what the research tells us about prognosis by stage for multicentric lymphoma:

Stages I–II: Relatively rare at diagnosis since lymphoma tends to spread quickly through the lymphatic system, but dogs caught at these early stages can have longer remission times with appropriate treatment. Because so few dogs are diagnosed at Stage I or II, large studies on these stages alone are limited.

Stage III–IV, substage A: This is where the majority of dogs are diagnosed. With aggressive multi-agent chemotherapy (like the CHOP protocol), approximately 80–90% of dogs with B-cell lymphoma achieve complete remission.⁷ Median survival times for B-cell lymphoma treated with CHOP range from 12 to 14 months, and roughly 20–25% of dogs survive beyond two years.^6,7 T-cell lymphomas in this category generally have shorter remission durations, with median survival times of approximately 6 to 9 months.^3,6

Stage V or substage B: More advanced disease that has spread to the bone marrow or is causing systemic illness. Prognosis is less favorable, but many dogs still respond to treatment and can achieve meaningful remission periods. Your oncologist may adjust the protocol to be more aggressive, add additional agents, or explore newer options. Dogs with substage B disease who convert to substage A (meaning their clinical signs resolve with treatment) often do significantly better than those whose clinical signs persist.^2,6

It's important to know that stage alone doesn't determine your dog's fate. Other factors — including lymphoma type (multicentric, alimentary, mediastinal, extranodal), cell type (B vs. T), the presence or absence of hypercalcemia, overall health, and how quickly treatment begins — all play significant roles in outcome. Even among dogs with the same stage and substage, individual responses to treatment can vary dramatically.

‍

Why the Right Treatment Matters More Than the Stage

Staging gives your oncologist essential information about the extent of disease, but the most critical factor in your dog's outcome is choosing the treatment most likely to work for their specific cancer. Two dogs with the exact same stage of lymphoma — even the same cell type — can respond very differently to the same chemotherapy protocol. One may achieve complete remission that lasts over a year, while the other may show minimal response.

This variability is exactly why precision medicine is changing the game for canine lymphoma treatment. Rather than relying solely on statistical averages to choose a protocol, precision medicine uses information specific to your individual dog's cancer to guide treatment decisions.

ImpriMed's drug response testing takes a sample of your dog's actual cancer cells and tests them against multiple chemotherapy drugs in the laboratory to predict which ones will be most effective. Instead of a one-size-fits-all approach, your oncologist gets data-driven guidance to build a personalized treatment plan — one that accounts for the unique biology of your dog's specific lymphoma.

This matters at every stage of the disease. For dogs newly diagnosed, it helps ensure the first-line treatment is the most effective one available. For dogs in relapse, it identifies rescue drugs most likely to achieve a second remission. Regardless of the stage, knowing which drugs will work best for your dog's cancer gives your oncologist the best possible foundation for treatment planning.

‍

Learn how ImpriMed helps oncologists choose the best treatment for your dog's cancer.